Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
ClinicalTrials.gov - Drug Trials For Money - Paid Clinical Trials

ClinicalTrials.gov

Author's Posts:
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
Condition:   Brain Metastases, Adult
Interventions:   Other: Laboratory Biomarker Analysis;   Other: Neurocognitive Assessment;   Other: Questionnaire Administration;   Device: Fitbit;   Dietary Supplement: Dietary Intervention
Sponsor:   Ohio State University Comprehensive Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 24, 2022 / by / in
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
Conditions:   Non-small Cell Lung Cancer;   Metastatic Non Small Cell Lung Cancer;   Nsclc;   NSCLC Stage IV;   Minimal Residual Disease;   Non Small Cell Lung Cancer Metastatic
Interventions:   Procedure: Local ablative therapy;   Other: Blood collection to assess for ctDNA
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 24, 2022 / by / in
Hydraderm for Androgenic Alopecia
Condition:   Androgenic Alopecia
Intervention:   Device: Venus Glow
Sponsor:   University of Minnesota
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 23, 2022 / by / in
Phase I Human Analytics (HALO) Study
Conditions:   Cardiovascular Diseases;   Cancer;   Dementia;   Traumatic Brain Injury
Intervention:   Other: no interventions will be performed (observational)
Sponsor:   Desert Medical Imaging
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Condition:   Non-Small Cell Lung Cancer
Intervention:  
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Condition:   Meningioma
Intervention:   Drug: Cabozantinib
Sponsors:   Baptist Health South Florida;   Exelixis
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Condition:   Colorectal Cancer
Interventions:   Drug: XL092;   Drug: Atezolizumab;   Drug: Regorafenib
Sponsors:   Exelixis;   Roche Pharma AG
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
Conditions:   Leukemia;   Non Hodgkin Lymphoma
Intervention:   Other: Interview
Sponsors:   University of Colorado, Denver;   Children’s Hospital Colorado
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Conditions:   Metastatic Prostate Cancer;   Neuroendocrine Prostate Cancer
Intervention:   Drug: ORIC-944
Sponsor:   ORIC Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 22, 2022 / by / in
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Condition:   Oropharyngeal Dysphagia
Interventions:   Biological: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR);   Other: Placebo
Sponsors:   University of California, Davis;   California Institute for Regenerative Medicine (CIRM);   Cook MyoSite
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 17, 2022 / by / in